SynthesisFuture oncology (London, England)2024

Efficacy and safety of VEGFR inhibitors for recurrent ovarian cancer: a systematic review.

Linlin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.